| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,562 |
1,995 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,022 |
883 |
$297.26 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
170 |
165 |
$42.78 |
| 80061 |
Lipid panel |
1,035 |
1,028 |
$0.00 |
| 80076 |
|
37 |
37 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
45 |
45 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,456 |
1,253 |
$0.00 |
| 99442 |
|
1,078 |
994 |
$0.00 |
| 82274 |
|
109 |
107 |
$0.00 |
| 91300 |
|
13 |
13 |
$0.00 |
| 1033F |
|
138 |
132 |
$0.00 |
| 82540 |
|
134 |
132 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
41 |
41 |
$0.00 |
| 86703 |
|
36 |
36 |
$0.00 |
| 83540 |
|
42 |
41 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18 |
15 |
$0.00 |
| 99173 |
|
21 |
14 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,290 |
1,286 |
$0.00 |
| 4450F |
|
446 |
439 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,678 |
2,401 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,534 |
1,431 |
$0.00 |
| 1220F |
|
438 |
426 |
$0.00 |
| 99443 |
|
54 |
51 |
$0.00 |
| 85027 |
|
282 |
262 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
431 |
424 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25 |
25 |
$0.00 |
| 82043 |
|
134 |
132 |
$0.00 |
| 90656 |
|
21 |
21 |
$0.00 |
| 1000F |
|
281 |
271 |
$0.00 |
| 90686 |
|
45 |
44 |
$0.00 |
| 99441 |
|
80 |
75 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
757 |
671 |
$0.00 |
| 2001F |
|
38 |
38 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
46 |
46 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
66 |
65 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
182 |
178 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
67 |
67 |
$0.00 |
| 81001 |
|
14 |
13 |
$0.00 |
| 87088 |
|
13 |
12 |
$0.00 |
| 85008 |
|
23 |
14 |
$0.00 |
| 86592 |
|
13 |
13 |
$0.00 |